Indian Pharma: The beginning of a long term bull run
Reading Time: 9 minutes
The outperformance of the Pharma sector during the current Covid-19 crisis is just the beginning of a long term bull run for the sector driven by reasonable valuation and multiple business tailwinds
Investing during COVID-19: The Long and Short of It
Reading Time: 10 minutes
Insights and strategies for investing during COVID-19. Learn about behaviour of HNIs, FIIs, AMCs and how business cycles will affect the markets.
Govt. reforms fail to uplift markets
Reading Time: 3 minutes
A host of reforms worth 20 lakh crore from the government to tackle covid-19 failed to uplift markets as benchmark indices closed in red
Anatomy of the Indian Pharma Industry
Reading Time: 5 minutes
The Indian pharma industry is the world’s 3rd largest by volume, the largest supplier of generic drugs & caters to ~50% of global vaccine demands.